Benzinga | Aug 5, 2021 07:42AM EDT

Harvard Bioscience Q2 EPS $0.06, Inline, Sales $29.20M Beat $27.67M Estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is a 20 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $29.20 million which beat the analyst consensus estimate of $27.67 million by 5.52 percent. This is a 25.27 percent increase over sales of $23.31 million the same period last year.